Related Experiment Video
Updated: Aug 6, 2026
10:37
Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
[Irritable bowel syndrome in the elderly]
Daisuke Sasaki1, Tsugumi Fukushi, Ken Sato
1Health Administration Center, Hirosaki University.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|August 11, 2006
Summary
Irritable bowel syndrome (IBS) affects 10-15% of people, yet its impact on the elderly is understudied. Further research is needed to understand how IBS manifests in older adults and to guide effective treatment.
Area of Science:
- Gastroenterology
- Gerontology
Background:
- Irritable bowel syndrome (IBS) is a prevalent gastrointestinal disorder affecting 10-15% of the global population.
- While IBS prevalence may decrease with age, it remains a significant health concern for the elderly population.
- There is a notable lack of research specifically investigating IBS in older adults.
Observation:
- Advancing age is associated with increased prevalence of chronic neurological, cardiovascular, and mental health conditions.
- The specific impact of aging on IBS presentation and its clinical course is largely unknown.
- Understanding how IBS manifests in the elderly is crucial for appropriate diagnosis and management.
Findings:
- The study highlights a significant knowledge gap regarding IBS in the elderly population.
- Aging may influence the presentation and management of IBS, necessitating age-specific considerations.
- Current research does not adequately address the unique challenges of IBS in older individuals.
Implications:
- Management strategies for IBS in the elderly must account for age-related comorbidities and physiological changes.
- There is a critical need for clinical therapeutic trials specifically designed for elderly IBS patients.
- Future research should focus on elucidating the pathophysiology and optimizing treatment protocols for IBS in aging populations.
Related Concept Videos
01:23Irritable Bowel Syndrome
DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility PatternsDisordered...
01:17Irritable Bowel Syndrome I: Introduction
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...